Therapy for Severe Psoriasis

A brand-new title in the field of dermatology, Therapy for Severe Psoriasis provides the ultimate coverage of the treatment options available for today's most serious cases, including biologics and oral therapies. It features discussions of the newest drug therapies, recent FDA-approved biosimilars, and combination approaches to care, while an overview chapter was designed to aid those new to the field in understanding the nuances of difficult-to-treat subtypes of psoriasis. Comprehensive and focused, Therapy for Severe Psoriasis will be a welcome addition to the library of any dermatologist seeking in-depth information on the challenges of this condition.

 

Jashin J. Wu, MD, FAAD, Director of Dermatology Research, Kaiser Permanente Los Angeles Medical Center, Los Angeles, CA, USA ; Steven R Feldman, MD, PhD, Professor of Dermatology, Pathology and Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC, USA and Mark G. Lebwohl, MD, Sol and Clara Kest Professor and Chairman of Dermatology, Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY